These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6981389)

  • 1. HLA B27, ankylosing spondylitis, and some normal rabbit sera.
    Mackintosh P; Pease P
    Ann Rheum Dis; 1982 Aug; 41(4):433-4. PubMed ID: 6981389
    [No Abstract]   [Full Text] [Related]  

  • 2. Blind confirmation of Geczy factor in ankylosing spondylitis.
    van Rood JJ; van Leeuwen A; Ivanyi P; Cats A; Breur-Vriesendorp BS; Dekker-Saeys AJ; Kijlstra A; van Kregten E
    Lancet; 1985 Oct; 2(8461):943-4. PubMed ID: 2865436
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors influencing the cytotoxicity of anti-bacterial sera for lymphocytes from ankylosing spondylitis patients.
    Archer JR; Stubbs MM; Geczy AF
    Clin Exp Rheumatol; 1988; 6(1):35-9. PubMed ID: 3260844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ankylosing spondylitis, HLA-B27, and Klebsiella: a study of lymphocyte reactivity of anti-Klebsiella sera.
    Singh B; Milton JD; Woodrow JC
    Ann Rheum Dis; 1986 Mar; 45(3):190-7. PubMed ID: 3485408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An antiserum to a disease-associated factor from the cells of an HLA-B27 positive patient with ankylosing spondylitis specifically recognizes an HLA-B27 associated determinant.
    Sullivan JS; Geczy AF
    Arthritis Rheum; 1987 Apr; 30(4):439-42. PubMed ID: 2437933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ankylosing spondylarthritis, HLA B27 and the theory of crossed tolerance].
    Ebringer A
    Rev Rhum Mal Osteoartic; 1983 Nov; 50(11):763-9. PubMed ID: 6364315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabbit antisera to enterobacteriaceae isolated from HLA-B27 positive patients with ankylosing spondylitis (AS) are lytic for the mononuclear cells of AS patients.
    Beukelman CJ; van Leeuwen A; Aerts PC; van Kregten E; van Bree S; van Rood JJ; Willers JM; van Dijk H
    Br J Rheumatol; 1988; 27 Suppl 2():58-60. PubMed ID: 3261191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ankylosing spondylitis, HLA-B27, and klebsiella.
    Geczy AF
    Ann Rheum Dis; 1986 Mar; 45(3):261-2. PubMed ID: 3485411
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiserum to Klebsiella K43 BTS 1 specifically lyses lymphocytes of HLA-B27-positive patients with ankylosing spondylitis from a London population.
    Archer JR; Stubbs MM; Currey HL; Geczy AF
    Lancet; 1985 Feb; 1(8424):344-5. PubMed ID: 2857398
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preparation and clinical application of HLA-B27 antisera].
    Liu DL
    Zhonghua Yi Xue Za Zhi; 1987 Mar; 67(3):144-6. PubMed ID: 3111660
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of HLA-B27 antigens on mononuclear leucocytes in ankylosing spondylitis.
    van der Gaag R; Luyendijk L; Linssen A; Kijlstra A
    Clin Exp Immunol; 1985 May; 60(2):311-5. PubMed ID: 3874023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute anterior uveitis, ankylosing spondylitis, back pain, and HLA-B27.
    Beckingsale AB; Davies J; Gibson JM; Rosenthal AR
    Br J Ophthalmol; 1984 Oct; 68(10):741-5. PubMed ID: 6236842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reinvestigation of the cross-reactivity between Klebsiella and HLA-B27 in the aetiology of ankylosing spondylitis.
    Georgopoulos K; Dick WC; Goodacre JA; Pain RH
    Clin Exp Immunol; 1985 Dec; 62(3):662-71. PubMed ID: 3878755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B27 and ankylosing spondylitis: an anti-idiotypic model.
    McLean IL; Adams DD; Highton J
    J Clin Lab Immunol; 1985 Nov; 18(3):123-7. PubMed ID: 3878886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B27, Klebsiella, and ankylosing spondylitis.
    Geczy AF; Yap J
    Lancet; 1979 Mar; 1(8118):719-20. PubMed ID: 85952
    [No Abstract]   [Full Text] [Related]  

  • 16. HLA-B27 associated cross-reactive marker on the cells of New Zealand patients with ankylosing spondylitis.
    McGuigan LE; Geczy AF; Prendergast JK; Edmonds JP; Hart HH; Bashir HV
    Ann Rheum Dis; 1986 Feb; 45(2):144-8. PubMed ID: 3484937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of HLA class I expression in ankylosing spondylitis.
    Creamer P; Edmonds J; Sullivan J; Matthews S
    Ann Rheum Dis; 1992 Oct; 51(10):1138-42. PubMed ID: 1444627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of ankylosing spondylitis in persons with the HLA-B27 antigen].
    Jajić I; Bastasić M; Kerhin V
    Reumatizam; 1984; 31(3-4):49-52. PubMed ID: 6334341
    [No Abstract]   [Full Text] [Related]  

  • 19. Ankylosing spondylitis, HLA-B27 and Klebsiella. I. Cross-reactivity studies with rabbit antisera.
    Welsh J; Avakian H; Cowling P; Ebringer A; Wooley P; Panayi G; Ebringer R
    Br J Exp Pathol; 1980 Feb; 61(1):85-91. PubMed ID: 6769456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of HLA associated disease: ankylosing spondylitis.
    Hammoudeh M; Khan MA
    J Rheumatol; 1983 Apr; 10(2):301-4. PubMed ID: 6602883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.